264
Views
9
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Prevention of ventricular fibrillation requires central β-adrenoceptor blockade in rabbits

, , &
Pages 221-229 | Received 21 Dec 2006, Published online: 12 Jul 2009

References

  • Freemantle N, Cleland J, Young P, Mason J, Harrison J. β-blockade after myocardial infarction: Systematic review and meta regression analysis. Br Med J. 1999; 318: 1730–7
  • Julian DG. Towards prevention of coronary death from ventricular fibrillation. Circulation. 1976; 54: 360–4
  • Bigger JT, Coromilas J. How do β-blockers protect after myocardial infarction?. Ann Intern Med. 1984; 101: 256–8
  • Skinner JE. Regulation of cardiac vulnerability by the cerebral defense system. J Am Coll Cardiol. 1985; 5: 88B–94B
  • Parker GW, Michael LH, Hartley CJ, Skinner JE, Entman ML. Central β-adrenergic mechanisms may modulate ischemic ventricular fibrillation in pigs. Circ Res. 1990; 66: 259–70
  • Lown B. Sudden cardiac death: Biobehavioral perspective. Circulation 1987; 76(Suppl)1: 186–96
  • Folkow B. Physiology of behaviour and blood pressure regulation in animals. In: Julius S, Bassett DR Handbook of hypertension. Behavioural factors in hypertension Amsterdam: Elsevier;Vol 9. 1987.
  • Åblad B, Bjurö T, Björkman J-A, Edström T, Olsson G. Role of central nervous β-adrenoceptors in the prevention of ventricular fibrillation through augmentation of cardiac vagal tone. J Am Coll Cardiol. 1991;17( Suppl):165. ( Abstract)
  • Åblad B, Abrahamsson T, Hultberg E, Majcherczyk S, Nerme V, Sjölander M. Pharmakologische Grundlagen. In: β-Rezeptoren-blockade. Die klinische Bedeutung der β1-Selektivität. München: Ed FW Lohmann; 1984.
  • van Zwieten PA, Timmermans PBMWM. Comparison between the acute hemodynamic effects and brain penetration of atenolol and metoprolol. J Cardiovasc Pharmacol. 1979; 1: 85–96
  • Coker SJ. The anesthetised rabbit as a model for ischemia and reperfusion induced arrhythmias: Effects of quinidine and bretylium. J Pharmacol Methods. 1989; 21: 263–79
  • Ervik M, Kylberg-Hanssen K, Johansson L. Determination of metoprolol in plasma and urine using high-resolution gas chromatography and electron-capture detection. J Chromatogr. 1986; 381: 168–74
  • Eriksson BM, Persson BA. Determination of catecholamines in rat heart tissue and plasma samples by liquid chromatography with electrochemical detection. J Chromatogr. 1982; 288: 143–54
  • Axenborg JE. BIOLAB – A computerized on-line system for physiological measurements in experimental animals. Computer Methods Prog Biomed. 1989; 28: 75–85
  • Pettersson K, Bejne B, Björk B, Strawn WB, Bondjers G. Experimental sympathetic activation causes endothelial injury in the rabbit thoracic aorta via β1-adrenoceptor activation. Circ Res. 1990; 67: 1027–34
  • Bengtsson C, Johnsson G, Regårdh CG. Plasma levels and effects of metoprolol on blood pressure and heart rate in hypertensive patients after an acute dose and between two doses during long-term treatment. Clin Pharmacol Ther. 1975; 17: 400–8
  • Leonetti G, Terzoli L, Bianchini C, Sala C, Zanchetti A. Time-course of the anti-hypertensive action of atenolol: Comparison of response to first dose and to maintained oral administration. Eur J Clin Pharmacol. 1980; 18: 365–74
  • Capone AJ, Most AS, Sydlik PA. Precordial ST segment mapping. A sensitive technique for the evaluation of myocardial injury?. Chest. 1975; 67: 577–82
  • Eckberg DL. Human sinus arrhythmia as an index of vagal cardiac outflow. J Appl Physiol. 1983; 54: 961–6
  • Potter EK. Inspiratory inhibition of vagal responses to baroreceptor and chemoreceptor stimuli in the dog. J Physiol. 1981; 316: 177–90
  • Schwartz PJ. The autonomic nervous system and life threatening arrhythmias. The nervous control of the heart, JT Shephard, SF Vatner. Harwood Academic Publishers GmbH, Amsterdam 1996; 329–355
  • Verrier RL, Lown B. Behavioural stress and cardiac arrhythmias. Ann Rev Physiol. 1984; 46: 155–76
  • Rozanski A, Blumenthal J A, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 1999; 99: 2192–217
  • Flügge G, Ahrens O, Fuchs E. β-adrenoceptors in the Tree Shrew Brain I. Distribution and characterization of [125I] Iodocyanopindolol Binding Sites. Cell Mol Neurobiol. 1997; 17: 401–15
  • Julian DG, Prescott RJ, Jackson FS, Szekely P. Controlled trial of sotalol for one year after myocardial infarction. Lancet. 1982; 319: 1142–7
  • CIBIS-II Investigators and Committees. The cardiac insufficiency bisoprolol study II (CIBIS II): A randomized trial. Lancet. 1999;353:9–13.
  • MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomised intervention trial in congestive heart failure. Lancet. 1999;353:2001–7.
  • Olsson G, Tuomilehto J, Berglund G, Elmfeldt D, Warnold I, Barber H, et al. Primary prevention of sudden cardiovascular death in hypertensive patients. Mortality results from the MAPHY study. Am J Hypertens. 1991; 4: 151–8
  • Carlberg B, Samuelsson O, Lindholm LH. Atenolol in hypertension: Is it a wise choice?. Lancet. 2004; 364: 1684–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.